MAC

Advertisement
Jan 09 2026HEALTH

Amazon Pharmacy Joins the Weight Loss Drug Game

Amazon Pharmacy has started selling Novo Nordisk's new weight loss pill, Wegovy. This pill is a big deal because it's the first oral version of a drug that was previously only available as an injection. The price is also quite attractive, with cash-paying customers able to get it for $149 a month. T

reading time less than a minute
Jan 09 2026HEALTH

Vaccine Changes: What's the Deal with U. S. Immunization Plans?

Merck, a big name in vaccines, recently spoke up about changes to the U. S. vaccine schedule for kids. They believe any changes should be based on solid science and expert advice. The CDC and other health groups recently moved some vaccines, like those for rotavirus and flu, to a category where pare

reading time less than a minute
Jan 09 2026SPORTS

Cricket Stars: Can They Bridge the India-Pakistan Divide?

Jason Holder, a well-known cricket player from the West Indies, has spoken out against the intense rivalry between India and Pakistan. He believes that the tension between these two cricket powerhouses has gone too far, especially after what happened at the Asia Cup 2025. Holder shared his thoughts

reading time less than a minute
Jan 09 2026SCIENCE

Unlocking New Paths to Mental Health Treatments

Mental health conditions like schizophrenia, bipolar disorder, and major depression are tricky. They don't just come from one gene. They come from many genes working together. Scientists have found that these genes often affect how brain cells grow and talk to each other. This makes finding new drug

reading time less than a minute
Jan 08 2026BUSINESS

A New Era for MannKind: What's Next in 2026?

MannKind, a company focused on treating long-term illnesses, had a strong finish to 2025. They acquired another company, scPharmaceuticals, and made over $100 million in their last quarter. This success has set the stage for an exciting 2026, with two major products potentially hitting the market.

reading time less than a minute
Jan 08 2026TECHNOLOGY

Mac Users Face Logitech App Meltdown

Logitech users on Mac faced a frustrating issue when the Logi Options+ app stopped working due to an expired security certificate. This problem caused custom buttons, gestures, and scrolling tweaks to stop functioning. The issue was not limited to the Options+ app; it also affected the G Hub softwar

reading time less than a minute
Jan 08 2026HEALTH

Small Molecules, Big Impact: Lilly's Bold Move to Tackle Inflammation

Lilly, a big name in medicine, is making a big move. They're buying Ventyx, a smaller company with a promising lineup of drugs. Ventyx's focus? Inflammation. They're working on small molecules that could treat a wide range of diseases caused by chronic inflammation. Think heart disease, brain disord

reading time less than a minute
Jan 08 2026HEALTH

Smart Tech Helps Doctors Decide Who Needs Heart Scans First

Heart scans, or echocardiograms, are super important for checking heart health. But there are not enough of them to go around. This means doctors need a smart way to decide who needs a scan first. A new study used fancy computer learning tricks to help with this. The study looked at both health and

reading time less than a minute
Jan 07 2026HEALTH

A New Hope for Tough-to-Treat Leukemia Patients

In a significant stride for medicine, a new drug combo is showing promise for people with a tough type of blood cancer. The combo, AB8939 plus venetoclax, is showing positive results in four patients who had run out of other options. These patients had a complex form of acute myeloid leukemia (AML),

reading time less than a minute
Jan 07 2026BUSINESS

Big Pharma's Urgent Quest for New Drugs

Big Pharma companies are in a rush to buy biotech firms. Why? They face a huge problem. Many of their top-selling drugs will soon lose patent protection. This is called the "patent cliff. " By 2032, they could lose over $170 billion in sales. To avoid this, they need new drugs fast. That's where bi

reading time less than a minute